- Research works
- 82 ▼ 31% vs 2013–17
- Citations
- 3.3k 40.2 per fractional work
- Top-10% rate
- 4.7% record average 16.5%
- Open access
- 56% world 28%
Not ranked overall: Instituto de Radiomedicina is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.2×. Every wedge is a field page.
- Medicine 3.2×
- Environmental Science 1.8×
- Immunology and Microbiology 1.3×
- Biochemistry, Genetics and Molecular Biology 1.3×
- Agricultural and Biological Sciences 1.0×
- Physics and Astronomy 1.0×
- Health Professions 0.8×
- Chemistry 0.7×
- Arts and Humanities 0.7×
- Earth and Planetary Sciences 0.6×
- Computer Science 0.6×
- Business, Management and Accounting 0.2×
- Engineering 0.1×
Who are the top researchers at Instituto de Radiomedicina?
Ranked on the composite score, Claudio V. Sole lead among researchers whose main affiliation is Instituto de Radiomedicina.
- 1 Claudio V. Sole Chile · #1,519,229 worldwide 3 citations · 18 works
Which keywords describe research at Instituto de Radiomedicina?
By fractional works in all years, weighted toward what it does more of than the world: Radiotherapy, Clinical Practice Guidelines, Chemotherapy, Survival Analysis, Neoadjuvant Therapy, Prognostic Factors, Prognostic Markers and Clinical Trials.
- Immunohistochemistry
- Ethical Considerations
- Genomic Profiling
- Mammography
- Radiotherapy Physics
- Dosimetry
- Resource Planning
- Health Economics
- Cancer Treatment
- Preoperative Chemoradiotherapy
- Endoscopic Resection
- Adjuvant Therapy
- Quality of Life
- Immunotherapy
- Breast Tumours
- Metastasis
- Clinical Trials
- Prognostic Factors
- Survival Analysis
- Clinical Practice Guidelines
- Radiotherapy
- Chemotherapy
- Neoadjuvant Therapy
- Prognostic Markers
- Breast Cancer
- Molecular Subtypes
- Gene Expression
- Biomarkers
- Surgical Management
- Medical Education
- Chemoradiation
- Biopsy
- Genetic Mutations
- Global Access
- Tumor Markers
- Image-Guided Radiotherapy
- Targeted Therapy
- Ultrasound
- Prostate Cancer
- Molecular Characterization
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Radiotherapy14▲ 44×11 topics
- Clinical Practice Guidelines11▲ 24×8 topics
- Chemotherapy10▲ 17×13 topics
- Survival Analysis8▲ 37×5 topics
- Neoadjuvant Therapy8▲ 43×5 topics
- Prognostic Factors6▲ 17×10 topics
- Prognostic Markers5▲ 69×3 topics
- Clinical Trials5▲ 9.5×4 topics
- Breast Cancer5▲ 20×8 topics
- Metastasis5▲ 17×6 topics
- Molecular Subtypes5▲ 64×2 topics
- Breast Tumours4▲ 111×1 topic
- Gene Expression4▲ 9.0×1 topic
- Immunotherapy4▲ 8.2×8 topics
- Biomarkers4▲ 8.4×4 topics
- Quality of Life4▲ 3.9×9 topics
- Surgical Management4▲ 11×10 topics
- Adjuvant Therapy3▲ 37×2 topics
- Medical Education3▲ 17×3 topics
- Endoscopic Resection3▲ 42×2 topics
- Chemoradiation3▲ 64×2 topics
- Preoperative Chemoradiotherapy3▲ 53×2 topics
- Biopsy3▲ 53×2 topics
- Cancer Treatment3▲ 14×4 topics
- Genetic Mutations3▲ 7.0×7 topics
- Health Economics3▲ 59×2 topics
- Global Access3▲ 60×1 topic
- Resource Planning3▲ 159×1 topic
- Tumor Markers3▲ 46×2 topics
- Dosimetry3▲ 35×2 topics
- Image-Guided Radiotherapy2▲ 59×1 topic
- Radiotherapy Physics2▲ 59×1 topic
- Targeted Therapy2▲ 14×4 topics
- Mammography2▲ 107×1 topic
- Ultrasound2▲ 25×1 topic
- Genomic Profiling2▲ 28×2 topics
- Prostate Cancer2▲ 18×3 topics
- Ethical Considerations2▲ 7.9×4 topics
- Molecular Characterization2▲ 14×3 topics
- Immunohistochemistry2▲ 26×3 topics
Which research topics does Instituto de Radiomedicina publish most on?
By volume in 2022–2025: Advances in Oncology and Radiotherapy, Management of metastatic bone disease, Palliative Care and End-of-Life Issues and Forest ecology and management.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Advances in Oncology and Radiotherapy Radiology, Nuclear Medicine and Imaging 2 works
- 2 Management of metastatic bone disease Surgery 1 works
- 3 Palliative Care and End-of-Life Issues Public Health, Environmental and Occupational Health 0 works
- 4 Forest ecology and management Nature and Landscape Conservation 0 works
- 5 Hepatocellular Carcinoma Treatment and Prognosis Hepatology 0 works
- 6 Seedling growth and survival studies Nature and Landscape Conservation 0 works
- 7 Health, Environment, Cognitive Aging Health, Toxicology and Mutagenesis 0 works
- 8 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 0 works
- 9 Botany and Geology in Latin America and Caribbean Ecology, Evolution, Behavior and Systematics 0 works
- 10 Cancer, Lipids, and Metabolism Cancer Research 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Instituto de Radiomedicina's research output changed?
Output in 2018–2022 was 31% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Santiago
- University of Chile
- Pontificia Universidad Católica de Chile
- Universidad de Santiago de Chile
- Universidad Diego Portales
- Alberto Hurtado University
- Adolfo Ibáñez University
- Universidad de Los Andes, Chile
- Hospital Clínico de la Universidad de Chile
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.